TABLE 3.
Clinical parameter | Control vs HCMV positive | Control vs reactivation | Control vs disease | Reactivation vs disease |
---|---|---|---|---|
Acute GvHD | 0.031 | 1.000 | 0.001 | <0.001 |
Chronic GvHD | 1.000 | 0.059 | 0.231 | 0.003 |
Corticosteroids (>2 mg/kg) | 0.143 | 0.036 | 0.452 | 0.959 |
CD34+ cell selection | 0.242 | 0.037 | 0.001 | <0.001 |
CMV serostatus,b +/+ | 0.005 | <0.001 | 0.250 | 0.390 |
CMV serostatus, +/− | 0.006 | 0.005 | 0.046 | 0.552 |
CMV serostatus, −/+ | 0.007 | <0.001 | 0.124 | 0.817 |
Patients in the control group did not show HCMV reactivation. Significant P values (<0.05) obtained by the Armitage trend test are underlined, and P values of <0.01 are in boldface. Positions of the SNPs in the respective genes were determined at http://snpper.chip.org/.
Serostatus of the donor/serostatus of the recipient.